发明名称 |
METHODS FOR THE TREATMENT OF CANCER USING GLIADIN PEPTIDES |
摘要 |
Kits and methods for treating cancer comprising administration of a gliadin peptide to a patient are disclosed herein. A kit according to the invention comprises a pharmaceutical composition comprising a gliadin peptide and instructions for administering the peptide to a patient. The kit may further comprise a pharmaceutical composition comprising at least one chemotherapeutic agent such as a receptor tyrosine kinase inhibitor and instructions for co-administering the compounds. A method of treating cancer according to the invention comprises administering a gliadin peptide to a patient and may further comprise co-administering at least one chemotherapeutic agent such as a receptor tyrosine kinase inhibitor. Co-administration of a gliadin peptide and receptor tyrosine kinase inhibitor to a patient with cancer is effective to decrease or prevent resistance of the cancer to the receptor tyrosine kinase inhibitor. |
申请公布号 |
US2016143991(A1) |
申请公布日期 |
2016.05.26 |
申请号 |
US201615007157 |
申请日期 |
2016.01.26 |
申请人 |
BARMARSA RESEARCH LLC |
发明人 |
Shaw Fred L. |
分类号 |
A61K38/16;A61K31/513;A61K31/517;A61K31/5377;A61K33/24;A61K36/899 |
主分类号 |
A61K38/16 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of treating cancer comprising administering a therapeutically effective amount of a gliadin peptide to a patient with cancer, wherein the gliadin peptide comprises the amino acid sequence set forth in SEQ ID NO:1 and wherein the cancer is selected from the group consisting of non-small cell lung cancer and pancreatic cancer. |
地址 |
Inverness IL US |